AFC HD AMS Life Science 1H Net Y881.00M Vs Net Y641.00M

Dow Jones

14 Apr

 AFC-HD AMS Life Science Co. Ltd. (2927.TO) 
Japan 
Half-Year Ended February 28 
GROUP 2025 2024 
Revenue Y16.61 bln Y14.54 bln 
Operating Profit Y1.29 bln Y1.02 bln 
Pretax Profit Y1.33 bln Y1.06 bln 
Net Profit Y881.00 mln Y641.00 mln 
Per share 
Earnings Y62.65 Y45.79 
Diluted Earnings Y62.64 Y45.74 
Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

 AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: 
GROUP Year Ending 
Aug 2025 
Revenue Y31.10 bln 
Operating Profit Y2.20 bln 
Pretax Profit Y2.20 bln 
Net Profit Y1.32 bln 
Per share 
Earnings Y93.78 
Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

April 14, 2025 02:36 ET (06:36 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2527974711"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527974711\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2527974711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-14 14:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527974711","market":"us","top_or_hot":-1,"title":"AFC HD AMS Life Science 1H Net Y881.00M Vs Net Y641.00M","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>AFC-HD AMS Life Science Co. Ltd. (2927.TO) </td><td></td></tr><tr><td></td><td>Japan </td><td></td></tr><tr><td></td><td>Half-Year Ended February 28 </td><td></td></tr><tr><td>GROUP</td><td>2025</td><td>2024 </td></tr><tr><td>Revenue</td><td>Y16.61 bln</td><td>Y14.54 bln </td></tr><tr><td>Operating Profit</td><td>Y1.29 bln</td><td>Y1.02 bln </td></tr><tr><td>Pretax Profit</td><td>Y1.33 bln</td><td>Y1.06 bln </td></tr><tr><td>Net Profit</td><td>Y881.00 mln</td><td>Y641.00 mln </td></tr><tr><td>Per share </td><td></td><td></td></tr><tr><td>Earnings</td><td>Y62.65</td><td>Y45.79 </td></tr><tr><td>Diluted Earnings</td><td>Y62.64</td><td>Y45.74 </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td><td></td></tr></tbody></table></pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: </td></tr><tr><td>GROUP</td><td>Year Ending </td></tr><tr><td></td><td>Aug 2025 </td></tr><tr><td>Revenue</td><td>Y31.10 bln </td></tr><tr><td>Operating Profit</td><td>Y2.20 bln </td></tr><tr><td>Pretax Profit</td><td>Y2.20 bln </td></tr><tr><td>Net Profit</td><td>Y1.32 bln </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>Y93.78 </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 02:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AFC HD AMS Life Science 1H Net Y881.00M Vs Net Y641.00M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAFC HD AMS Life Science 1H Net Y881.00M Vs Net Y641.00M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-14 14:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>AFC-HD AMS Life Science Co. Ltd. (2927.TO) </td><td></td></tr><tr><td></td><td>Japan </td><td></td></tr><tr><td></td><td>Half-Year Ended February 28 </td><td></td></tr><tr><td>GROUP</td><td>2025</td><td>2024 </td></tr><tr><td>Revenue</td><td>Y16.61 bln</td><td>Y14.54 bln </td></tr><tr><td>Operating Profit</td><td>Y1.29 bln</td><td>Y1.02 bln </td></tr><tr><td>Pretax Profit</td><td>Y1.33 bln</td><td>Y1.06 bln </td></tr><tr><td>Net Profit</td><td>Y881.00 mln</td><td>Y641.00 mln </td></tr><tr><td>Per share </td><td></td><td></td></tr><tr><td>Earnings</td><td>Y62.65</td><td>Y45.79 </td></tr><tr><td>Diluted Earnings</td><td>Y62.64</td><td>Y45.74 </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td><td></td></tr></tbody></table></pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: </td></tr><tr><td>GROUP</td><td>Year Ending </td></tr><tr><td></td><td>Aug 2025 </td></tr><tr><td>Revenue</td><td>Y31.10 bln </td></tr><tr><td>Operating Profit</td><td>Y2.20 bln </td></tr><tr><td>Pretax Profit</td><td>Y2.20 bln </td></tr><tr><td>Net Profit</td><td>Y1.32 bln </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>Y93.78 </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 02:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0354030511.USD","symbol_name":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527974711","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527974711","pubTimestamp":1744612560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","BK4196":"保健护理服务","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","HD":"家得宝","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","BK4550":"红杉资本持仓","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4588":"碎股","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","BK4083":"家庭装潢零售","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","LU0823411888.USD":"法巴消费创新基金 Cap","BK4581":"高盛持仓","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0079474960.USD":"联博美国增长基金A","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","BK4504":"桥水持仓","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","M11.SI":"综合制造科技","BK4567":"ESG概念","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4585":"ETF&股票定投概念","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","BK4534":"瑞士信贷持仓","AMS":"American Shared Hospital Services","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC"},"translate_title":"AFC HD AMS生命科学1H净值Y881.00M Vs净值Y641.00M","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMS":1,"HD":1,"M11.SI":1},"content_text":"AFC-HD AMS Life Science Co. Ltd. (2927.TO) Japan Half-Year Ended February 28 GROUP20252024 RevenueY16.61 blnY14.54 bln Operating ProfitY1.29 blnY1.02 bln Pretax ProfitY1.33 blnY1.06 bln Net ProfitY881.00 mlnY641.00 mln Per share EarningsY62.65Y45.79 Diluted EarningsY62.64Y45.74 Results are based on Japanese accounting standards. \n\n  (END) Dow Jones Newswires\n\n\nAFC-HD AMS Life Science Co. Ltd. also released the following forecasts: GROUPYear Ending Aug 2025 RevenueY31.10 bln Operating ProfitY2.20 bln Pretax ProfitY2.20 bln Net ProfitY1.32 bln Per share EarningsY93.78 Results are based on Japanese accounting standards. \n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 02:36 ET (06:36 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}